Primary Record
GDC-0879
Note: Only for scientific research or as raw materials for production.
- In stock
- 4,605 g
- Purity
- 98.6 %
- CAS
- 905281-76-7
Compound Identifiers & Properties
- CAS
- 905281-76-7
- PubChem CID
- 11717001
- SMILES
- C1C/C(=N\O)/C2=C1C=C(C=C2)C3=CN(N=C3C4=CC=NC=C4)CCO
- Canonical SMILES
- OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1
Names & Synonyms
- GDC-0879
- 905281-76-7
- GDC0879
- GDC 0879
- RefChem:142768
- E488J6BA6E
- GDC-0879 Hydrochloride
- CHEBI:83405
- D03TTT
- CHEMBL525191
- UNII-E488J6BA6E
- cc-213
- DTXSID00471110
- C19H18N4O2
- GTPL5681
- orb1300873
- SCHEMBL2467603
- SCHEMBL29355995
- DTXCID30421926
- B-Raf kinase inhibitors (cancer)
- MFCD16875916
- BCPP000222
- AMY20724
- Anticancer program, Array/Genentech
- AR-00341677
- EX-A2357
- GDC-0879,GDC0879
- GDC-0879/GDC0879
- ABP000427
- BDBM50029085
- s1104
- ZINC34640412
- AKOS015856553
- BCP9000714
- CCG-264821
- CS-0158
- FH43320
- RL05696
- SDCCGSBI-0654339.P001
- CID11717001
- (E)-5-(1-(2-hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime
- 4-(1-methyl-1H-pyrazol-5-yl)pyridine
- NCGC00263179-09
- AC-36041
- AN-16804
- AR 00341677
- CID:11717001
- HY-50864
- MS-25046
- QC-11137
- SC-28255
- (E)-5-(1-(2-hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydroinden-1-one oxime
- BCP0726000314
- SID:251963966
- AB0008140
- DB-000743
- AR00341677
- GDC-0879, >=98% (HPLC)
- X7405
- EC-000.2334
- A10420
- A10801
- W-3495
- 2-[4-[(1E)-1-hydroxyimino-2,3-dihydroinden-5-yl]-3-pyridin-4-ylpyrazol-1-yl]ethanol
- B-Raf kinase inhibitors (cancer), Array/Genentech
- C540167
- 2230954-03-5
- BRD-K67578145-001-01-4
- BRD-K67578145-001-09-7
- BRD-K67578145-001-10-5
- BRD-K67578145-001-12-1
- Q27077781
- (E)-5-(1-(2-hydroxyethyl)-3-(pyridin-4-yl)-1H-pyra
- 5-[1-(2-hydroxyethyl)-3-(4-pyridyl)pyrazol-4-yl]indan-1-one oxime
- GDC0879, GDC 0879, 905281-76-7
- (E)-5-(1-(2-Hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one
- 2,3-Dihydro-5-[1-(2-hydroxyethyl)-3-(4-pyridinyl)-1H-pyrazol-4-yl]-1H-inden-1-one oxime
- 5-(1-(2-Hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime
- 5-(1-(2-Hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydroinden-1-one oxime
- 1H-Inden-1-one, 2,3-dihydro-5-(1-(2-hydroxyethyl)-3-(4-pyridinyl)-1H-pyrazol-4-yl)-, oxime
- 1H-Inden-1-one, 2,3-dihydro-5-(1-(2-hydroxyethyl)-3-(4-pyridinyl)-1H-pyrazol-4-yl)-, oxime, (1E)-
- 2-{4-[(1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridin-4-yl)-1H-pyrazol-1-yl}ethan-1-ol
- 2-{4-[(1e)-1-(Hydroxyimino)-2,3-Dihydro-1h-Inden-5-Yl]-3-(Pyridin-4-Yl)-1h-Pyrazol-1-Yl}ethanol
- (E)-5-(1-(2-hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydroinden-1-oneoxime
- 2,3-dihydro-5-(1-(2-hydroxyethyl)-3-(4-pyridinyl)-1h-pyrazol-4-yl)-1h-inden-1-one oxime
- 2-[4-[(1E)-1-hydroxyimino-2,3-dihydroinden-5-yl]-3-pyridin-4-yl-pyrazol-1-yl]ethanol
- 2-{4-[(1E)-1-(hydroxyimino)-2,3-dihydroinden-5-yl]-3-(pyridin-4-yl)pyrazol-1-yl}ethanol
- 5-[1-(2-Hydroxy-ethyl)-3-pyridin-4-yl-1H-pyrazol-4-yl]-indan-1-one oxime
- (E)-2,3-Dihydro-5-[1-(2-hydroxyethy l)-3-(4-pyridinyl)-1H-pyrazol-4-yl]-1H-inden-1-one oxime
- (E)-2,3-Dihydro-5-[1-(2-hydroxyethyl)-3-(4-pyridinyl)-1H-pyrazol-4-yl]-1H-inden-1-one oxime
- 2-(4-((1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl)-3-(pyridin-4-yl)-1H-pyrazol-1-yl)ethan-1-ol
- 2-(4-(1-(hydroxyimino)-2,3-dihydro-1h-inden-5-yl)-3-(pyridin-4-yl)-1h-pyrazol-1-yl)ethan-1-ol